Table 1.
Clinical and demographic characteristics of study participants by group.
| Overall Median | NPN | PN | SPN | p value | |
|---|---|---|---|---|---|
|
| |||||
| Number | 38 | 20 | 13 | ||
|
| |||||
| Age (years) | 36 | 34 (27–42) | 40 (31–47) | 37 | 0.05* 0.33ψ |
|
| |||||
| Years of education | 16 | 16 | 15 | 14 | 0.13* 0.06ψ |
|
| |||||
| Days post HIV transmission | 107 | 104 (65–188) | 125 (74–164) | 137 (72–172) | 0.87* 0.91ψ |
|
| |||||
| CD4+ T cellcount (cells/ul) | 575 | 558 (408–729) | 582(453–715) | 601 (483–755) | 0.83* 0.41ψ |
|
| |||||
| CD8+ T cell count (cells/ul) | 985 | 701 (513–1202) | 1019 (674–1543) | 1053 (736–1635) | 0.59* 0.33ψ |
|
| |||||
| Plasma HIV RNA (log10 copies/mL) | 4.45 | 4.37 (3.94–4.77) | 4.79 (3.17–5.18) | 4.82 (3.00–5.28) | 0.29* 0.25ψ |
|
| |||||
| Race/Ethnicity | |||||
| White, n (%) | 29 (49.2) | 10 (17.2) | 8 (13.8) | 0.08* 0.35ψ |
|
|
| |||||
| History of IV drug use | |||||
| Yes, n (%) | 27 (46.6) | 16 (27.6) | 10 (17.2) | 0.72* 0.52ψ |
|
|
| |||||
| History of alcohol use | |||||
| Yes, n (%) | 12 (20.7) | 13 (22.4) | 8 (13.8) | 0.05* | |
| Unknown, n (%) | 3 (7.9) | 0 | 0 | 0.65ψ | |
|
| |||||
| Hepatitis C infection status | |||||
| Yes, n (%) | 1 (2.6) | 0 | 0 | ||
| Unknown, n (%) | 5 (13.2) | 0 | 0 | ||
Abbreviations:
NPN = no peripheral neuropathy. PN = peripheral neuropathy. SPN = symptomatic peripheral neuropathy.
Values are presented as medians (IQR) unless otherwise noted.
*
NPN vs. PN
ψ
SPN vs. PN